Expertise in
53
conditions

Dr. Joseph M. Pascuzzo

Oncology
Cancer Imaging Associates
1791 E Fir Ave, 
Fresno, CA 
Offers Telehealth
Expertise in
53
conditions
Cancer Imaging Associates
1791 E Fir Ave, 
Fresno, CA 

Overview

Joseph Pascuzzo is an Oncologist practicing medicine in Fresno, California.

Dr. Pascuzzo is highly rated in 53 conditions, according to our data. His clinical expertise encompasses Vitamin B12 Deficiency, Myelodysplastic Syndrome (MDS), Melanoma, and Thrombocytopenia.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 2 clinical trials.

Specialties

Oncology

Licenses

Hospice and Palliative Medicine in CA

Hospital Affiliations

Saint Agnes Medical Center
Clovis Community Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Cancer Imaging Associates
1791 E Fir Ave, Fresno, CA 93720

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (Bintrafusp Alfa) Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
An Adaptive Phase III, Multicenter, Randomized, Open-Label, Controlled Study of M7824 (Bintrafusp Alfa) Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 08, 2025
Intervention Type: Drug
Study Drugs: M7824, Pembrolizumab
Study Phase: Phase 3
An Open-Label, Randomized-Sequence, Multicenter, Single-Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Formulation Compared to Niraparib Capsule Formulation in Patients With Advanced Solid Tumors
An Open-Label, Randomized-Sequence, Multicenter, Single-Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Formulation Compared to Niraparib Capsule Formulation in Patients With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: July 25, 2024
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

1 Total Publications

A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
Journal: Clinical therapeutics
Published: September 22, 2023
Similar Doctors
Expertise in
68
conditions
Dr. Haifaa Abdulhaq
Hematology | Oncology
Expertise in
68
conditions
Dr. Haifaa Abdulhaq
Hematology | Oncology
Referral may be required

University Oncology Associates Inc.

2335 E Kashian Ln Ste 301, 
Fresno, CA 
 (6.5 miles away)
559-256-9680
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Haifaa Abdulhaq is a Hematologist and an Oncologist practicing medicine in Fresno, California. Dr. Abdulhaq is highly rated in 68 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Tissue Biopsy.

Expertise in
87
conditions
Expertise in
87
conditions
Referral may be required

California Cancer Associates For Research And Excellence Inc.

7130 N Millbrook Ave Ste 100, 
Fresno, CA 
 (1.7 miles away)
559-447-4949
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ravi Rao is an Oncologist practicing medicine in Fresno, California. Dr. Rao is highly rated in 87 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Thrombocytopenia.

Expertise in
32
conditions
Dr. Dina Ibrahim
Hematology | Oncology
Expertise in
32
conditions
Dr. Dina Ibrahim
Hematology | Oncology
Referral may be required

Jeffrey K Shinoda Pharm D Inc

6121 N Thesta St Ste 204, 
Fresno, CA 
 (1.3 miles away)
559-554-2100
Languages Spoken:
English
See accepted insurances

Dina Ibrahim is a Hematologist and an Oncologist practicing medicine in Fresno, California. Dr. Ibrahim is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer.

Frequently Asked Questions about Dr. Joseph M. Pascuzzo

How do I make an appointment with Dr. Joseph M. Pascuzzo?

You can book an appointment with Dr. Joseph M. Pascuzzo by calling their office at 559-326-1222. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joseph M. Pascuzzo a top-rated expert for Vitamin B12 Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph M. Pascuzzo is classified as an Distinguished expert for Vitamin B12 Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joseph M. Pascuzzo specialize in?

While Dr. Joseph M. Pascuzzo is a Oncology, they have specific expertise in Vitamin B12 Deficiency, Myelodysplastic Syndrome (MDS), and Melanoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Joseph M. Pascuzzo participate in research or clinical trials?

Yes. Dr. Joseph M. Pascuzzo has published 1 articles and abstracts on conditions like Vitamin B12 Deficiency. You can view a list of Dr. Joseph M. Pascuzzo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joseph M. Pascuzzo accept my insurance?

Dr. Joseph M. Pascuzzo accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 559-326-1222 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pascuzzo's expertise for a condition
ConditionClose
    View All 47 Advanced Conditions
    View All 110 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile